Navigation Links
Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
Date:2/13/2008

between $1.64 and $1.72, based on approximately 56 million

fully diluted shares outstanding for the year and a tax rate of 35%.

Recent Events

-- PROCLEIX ULTRIO Post-Marketing Study. Gen-Probe believes the Company

has met its goal of identifying a second case of hepatitis B "yield"

in the post-marketing study for the PROCLEIX ULTRIO assay. Yield is

defined as an HBV-infected blood donation that was intercepted by the

PROCLEIX ULTRIO assay, but that was initially negative based on

traditional serology tests. To date, participating blood banks have

screened approximately 500,000 blood donations in the study. The FDA

has approved the PROCLEIX ULTRIO assay to screen donated blood for

HIV-1 and hepatitis C virus (HCV), but not to screen for HBV, as the

initial clinical studies were not designed to, and did not,

demonstrate HBV yield. Within a month, Gen-Probe intends to submit a

supplemental Biologics License Application (BLA) to the US Food and

Drug Administration in hopes of gaining a donor screening claim for

HBV.

-- Carl Hull Named President and COO. On February 11, Gen-Probe

announced that Carl Hull was named the Company's president and chief

operating officer, effective March 1, 2008. Mr. Hull joined Gen-Probe

in February of 2007 as executive vice president and chief operating

officer. He oversees the Company's major operating functions,

including research and development, manufacturing, and sales and

marketing.

-- New Operations Executive. On November 19, Gen-Probe announced that

Jorgine Ellerbrock joined the Company as senior vice president,

operations. She joined the Company from Invitrogen Corporation, where

she had been vice president, operations, since 2004, most recently for

the Molecul
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Carl Hull Named President and Chief Operating Officer of Gen-Probe
2. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
5. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
6. Imagenetix Inc. Reports Third Fiscal Quarter Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)... FRANCISCO, Calif. , Dec. 17, 2014 /PRNewswire/ ... of a Phase 2 study evaluating the investigational ... treatment of patients with severe, chronic itch who ... standard of care, including topical steroids and antihistamines. ... percent change in Visual Analog Scale (VAS) itch ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... December 12, 2014 Clarassance, a privately ... its new name: Therabron Therapeutics , Inc. The ... bronchioles (a type of structure in the lungs similar ... mission to develop novel protein therapeutics for the treatment ... decided to change the name to mark the company's ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Production Efficiency and Manage Quality at New LIFE Nutrition ... Honeywell (NYSE: HON ) today announced that ... global manufacturer of healthcare products, to provide process control ... nutrition and infusion therapy solutions. The Leading Infusion Factory ...
... 27 Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE ... Vice President of Research and Development, will be presenting pre-clinical ... Meeting of the American Society of Gene Therapy, which is ... Diego, CA, from Wednesday, May 27th through to Saturday, May ...
... MONICA, Calif., May 27 Cord Blood America, Inc. (OTC ... company ( http://www.cordblood-america.com ) focused ... families nationwide and internationally, said today that it has reduced ... the first five months of 2009. "On April 6th, ...
Cached Biology Technology:Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 2Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 3Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 4Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy 2Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy 3Cord Blood America Says Debt Reduced $4.194 Million in 2009 2
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
(Date:12/10/2014)...  Wake Forest Baptist Medical Center today announced plans for ... Medicine. Funding for this $50 million capital project is ... publicly launched next summer. The medical ... series R.J. Reynolds Tobacco Company complex, adjacent to 525@vine ... with plans to be ready to welcome medical students ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and Markets ... addition of the "Biometrics Market in Japan ... http://photos.prnewswire.com/prnh/20130307/600769 The ... such as rural banking and upgradation of the ... witnessed in the market. Besides the aforementioned projects, ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... the first study of its kind, researchers at Queens ... that low socioeconomic status (SES) and maternal gestational diabetes ... deficit hyperactivity disorder (ADHD) in six year olds. The ... Archives of Pediatrics and Adolescent Medicine , one ...
... of a microRNA promotes progressive muscle deterioration in a ... a study published online on January 2 in the ... As DMD patients age, their damaged muscle cells ... fibrosis is partly induced by the growth factor TGF-beta, ...
... Millbrook, N.Y. -- On January 2nd, WAMC Northeast Public Radio ... new radio show called Earth Wise: A look at our ... among radio listeners, with a focus on raising awareness about ... segments will air Monday through Friday at 11:10 AM and ...
Cached Biology News:Gestational diabetes and low socioeconomic status raise risk of ADHD in children 2A firmer understanding of muscle fibrosis 2Cary Institute and WAMC debut new environment radio show 2
CKB Antibody (N-term) Antigen: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected within aa 1~100 of human CKB. Molecular Weight: 42644 Da...
...
The antibody recognizes the peptide sequence ESESQGPK (aa 441-448) of human class III beta-tubulin specific for neurones....
... polyacrylamide gel electrophoresis (2D-PAGE) with biological mass ... technology platform for proteomic analysis. 2D-PAGE gels ... limited only in the dynamic range and ... Quantitative image based analysis of separated proteins ...
Biology Products: